Abiraterone plus prednisone alone or with dasatinib in chemotherapy-naive metastatic castrate-resistant prostate cancer (mCRPC). Background: Strategies that integrate systemic therapy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results